Dr. George Waring successfully performed the first FDA-approved implantation in the United States of the BVI FineVision® HP Trifocal Intraocular Lens (IOL) earlier today, marking a significant milestone in the advancement of presbyopia-correcting cataract surgery.
The BVI FineVision HP Trifocal IOL is designed to provide patients with high-quality vision at near, intermediate, and distance ranges, offering a full range of vision with reduced dependence on glasses following cataract surgery. Its FDA approval represents a major step forward in expanding advanced vision correction options for U.S. patients.
“This is an exciting moment for both surgeons and patients,” said Dr. George Waring, medical director of Waring Vision Institute. “The availability of the BVI FineVision HP Trifocal IOL in the United States allows us to offer an innovative, clinically proven technology that has the potential to significantly enhance visual outcomes and patient satisfaction.”
The lens features a trifocal optical design engineered to optimize light distribution and visual quality across all distances.
“This milestone underscores our commitment to innovation and to bringing the latest FDA-approved technologies to our patients,” Dr. Waring added.
The first implantation signals the beginning of broader U.S. availability of the BVI FineVision HP Trifocal IOL and highlights the ongoing evolution of premium cataract and refractive lens surgery.
About Waring Vision Institute
Waring Vision Institute, located in Charleston, South Carolina, is a premier destination for innovative and luxurious eye care. Led by a world-class surgeon, Dr. George O. Waring IV, the Institute specializes in the latest advancements in laser vision correction, cataract surgery, and a wide range of other ophthalmic services. With a commitment to personalized care and advanced technology, Waring Vision Institute delivers an unparalleled experience for every patient. For more information, visit www.waringvision.com.
Media Contact
Jessica Stubing
jstubing@waringvision.com
